November 09, 2010 10:26
NPERC, Bayer to conduct joint research on biodegradable injection
Shanghai. November 9. INTERFAX-CHINA - The National Pharmaceutical Engineering Research Center (NPERC), a subsidiary of the Shanghai Institute of Pharmaceutical Industry (SIPI), has signed an agreement with German giant Bayer Schering Pharma AG to conduct joint research on a biodegradable injection drug delivery system, SIPI announced Nov. 8.
The announcement did not disclose the financial terms of the agreement.
NPERC is currently working on 10 different technologies for dosage preparation and drug delivery, including biodegradable microspheres, liposome preparations, a bioadhesive dosage form and an oral suspension sustained release system.
September 25, 2016
Oil output reduction artificially in Russia not discussed - Novak
OIL OUTPUT REDUCTION ARTIFICIALLY IN RUSSIA NOT DISCUSSED - NOVAK
Cybercrime rates in Russia rose fourfold this year - Prosecutor General's Office
Russian, U.S. goals in Syria diametrically opposed - expert
Russian army engineering troops' training center increases number of trained sniffer dogs more than fivefold - Russian Defense Ministry
Those demanding Russia's proof of commitment to peaceful resolution of Syrian conflict must prove themselves that they are not aggressors - Russian Foreign Ministry
THOSE DEMANDING FROM RUSSIA PROOF OF COMMITMENT TO PEACEFUL RESOLUTION OF SYRIAN CONFLICT MUST PROVE THEMSELVES THAT THEY ARE NOT AGRESSORS - RUSSIAN FOREIGN MINISTRY
West wants to blame Russia for escalation in Syria, that is aim of UN SC convocation - Klintsevich
Separating of combatants in Donbas to begin in Petrovske on Oct 1 - Basurin
Georgian border guards to receive two U.S. patrol boats as gift
Jock Sturges' controversial exhibition in Moscow could be closed (Part 3)
Rosatom not commenting on media allegations of Kiriyenko's transfer to Russian presidential administration (Part 2)
Rosatom not commenting on media allegations of Kiriyenko's transfer to Russian presidential administration
Jock Sturges' controversial exhibition in Moscow could be closed (Part 2)